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Embryonic development is controlled by a small set of signal transduction pathways, with vastly
different phenotypic outcomes depending on the time and place of their recruitment. How the same
molecular machinery can elicit such speciﬁc and distinct responses, remains one of the outstanding
questions in developmental biology. Part of the answer may lie in the high inherent genetic complexity
of these signaling cascades, as observed for the Wnt-pathway. The mammalian genome encodes
multiple Wnt proteins and receptors, each of which show dynamic and tightly controlled expression
patterns in the embryo. Yet how these components interact in the context of the whole organism
remains unknown. Here we report the generation of a novel, inducible transgenic mouse model that
allows spatiotemporal control over the expression of Wnt5a, a protein implicated in many develop-
mental processes and multiple Wnt-signaling responses. We show that ectopic Wnt5a expression from
E10.5 onwards results in a variety of developmental defects, including loss of hair follicles and reduced
bone formation in the skull. Moreover, we ﬁnd that Wnt5a can have dual signaling activities during
mouse embryonic development. Speciﬁcally, Wnt5a is capable of both inducing and repressing
b-catenin/TCF signaling in vivo, depending on the time and site of expression and the receptors
expressed by receiving cells. These experiments show for the ﬁrst time that a single mammalian Wnt
protein can have multiple signaling activities in vivo, thereby furthering our understanding of how
signaling speciﬁcity is achieved in a complex developmental context.
& 2012 Elsevier Inc. All rights reserved.Introduction
In all multicellular animals, tissue morphogenesis is regulated
by the concerted activities of a limited number of developmental
signal transduction pathways, including Wnt, Hedgehog and
Notch (Gerhart, 1999). Over the past thirty years our knowledge
regarding the molecular nature of the intracellular signaling
events triggered by pathway activation has steadily increased.
However, we have only begun to scratch the surface when it
comes to understanding how these same molecular pathways can
be used over and over again, at multiple developmental sites
and time points, with vastly different phenotypic outcomes.
One reason for our apparent lack of understanding signal trans-
duction in the context of an intact, multicellular animal, is thell rights reserved.
merongen),
, Plesmanlaan 121, 1066 CX
de Lausanne (EPFL) SV ISREC,obvious intricacy of the organism under study: At any one time a
given cell will ﬁnd itself capable of receiving simultaneous inputs
from multiple sources, including the extracellular environment
and neighboring cells, and in a developing organism these
surroundings are rapidly and continually changing. Equally
important however, is the high complexity of the developmental
signaling pathways themselves. An illustrative example is that of
the Wnt-pathway, a major player in development, physiology and
disease (Croce and McClay, 2008; Klaus and Birchmeier, 2008;
MacDonald et al., 2009), which uses a large number of extra-
cellular ligands (Wnts) and transmembrane receptors (Fzd) to
elicit a diverse array of intracellular signaling responses.
Both ligands and receptors belong to large, multi-gene
families: The mammalian genome encodes 19 Wnt and 10 Fzd
homologues, totaling 190 different potential ligand/receptor pair-
ings. Of note, this complexity is conserved in lower organisms,
with the sea anemone Nematostella showing conservation of 11 of
the 12 Wnt subfamilies (Kusserow et al., 2005). Further complica-
tion arises from the presence of additional (co-)receptors,
and secreted inhibitors or co-activators, which help shape the
signaling response (see for instance (Mii and Taira, 2009)).
Furthermore, Wnt proteins can elicit multiple intracellular
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characterized response downstream of Wnt/Fzd binding results in
the activation of b-catenin/TCF transcriptional complexes (here-
after ‘Wnt/b-catenin signaling’) and requires the recruitment of
LRP5/6 co-receptors (Pinson et al., 2000; Tamai et al., 2000;
Wehrli et al., 2000). For many years, Wnt proteins themselves
were classiﬁed as either ‘canonical’ or ‘non-canonical’ based
on their (in)ability to activate Wnt/b-catenin signaling
(Du et al., 1995; Shimizu et al., 1997; Wong et al., 1994). This strict
subdivision was challenged, however, by the ﬁnding that a given
Wnt can be turned into an activator of Wnt/b-catenin signaling
when provided with the appropriate receptor (He et al., 1997).
In light of this complexity, a key question then is how signaling
speciﬁcity is achieved in a developmental context. One step towards
answering this question will come from determining whether differ-
ent, and if so which, combinations of ligands and receptors trigger
speciﬁc signaling outcomes. To date however, it has proven a
challenge to determine binding afﬁnities for speciﬁc Wnt/Fzd com-
plexes. Most efforts have stalled due to the hydrophobic nature of the
Wnt proteins and the concomitant difﬁculty of purifying them.
Although this hurdle has been overcome for some Wnt proteins
(Mikels and Nusse, 2006; Willert et al., 2003), it has prevented
comprehensive quantitative biochemical analyses in vitro. Both Wnts
and Fzds display tightly regulated and highly dynamic spatiotemporal
expression patterns within the developing organism (Fischer et al.,
2007; Summerhurst et al., 2008; Witte et al., 2009), suggesting
equally dynamic ligand/receptor interactions. Although some Wnt/
receptor pairings appear to be more likely than others (Carmon and
Loose, 2010; Hsieh et al., 1999; Mikels and Nusse, 2006; Takada et al.,
2005; Wu and Nusse, 2002), at present it remains largely unknown
which ligands engage which receptors under which circumstances.
One particularly intriguing Wnt protein is Wnt5a, which has
been implicated in many developmental processes and which can
activate multiple intracellular signaling responses. Our lab pre-
viously showed that mouse Wnt5a, which is typically not found
to activate a b-catenin/TCF responsive reporter gene, was able to
induce Wnt/b-catenin signaling in 293 cells overexpressing Fzd4
and LRP5 (Mikels and Nusse, 2006). In their absence, however, the
cells responded to Wnt5a by inhibiting Wnt3A-mediated signal-
ing through b-catenin/TCF. The capacity of Wnt5a to inhibit Wnt/
b-catenin signaling has been reported in multiple systems and
organisms (Li et al., 2010; Olson and Gibo, 1998; Topol et al.,
2003; Torres et al., 1996) and is mediated through the receptor
tyrosine kinase Ror2, which has been reported to function as
either a co-receptor or a bona-ﬁde Wnt-receptor (Green et al.,
2007; Grumolato et al., 2010; Mikels et al., 2009; Nishita et al.,
2010). In addition to the above, Wnt5a can also induce alternative
signaling responses that appear to proceed independently from
b-catenin. Although many of these remain poorly characterized at
the biochemical level, they too have been reported to involve Fzd
as well as Ror2 receptors (Nishita et al., 2010; Nomachi et al.,
2008; Oishi et al., 2003; Sato et al., 2010).
Wnt5a-knockout mice have a variety of phenotypes, including
skeletal defects (Yamaguchi et al., 1999) and multiple defects
associated with internal organs (Allgeier et al., 2008; Andersson
et al., 2008; Cervantes et al., 2009; Cha et al., 2004; He et al., 2008;
Kim et al., 2005; Li et al., 2002; Qian et al., 2007; Roarty et al.,
2009; Tai et al., 2009). Interestingly, the phenotype of Ror-
knockout mice resembles that of Wnt5a-knockout mice. Both
display dwarﬁsm, craniofacial defects, limb abnormalities and
intestinal elongation defects (Ho et al., 2012; Oishi et al., 2003;
Takeuchi et al., 2000; Yamada et al., 2010). In addition, both Ror2
and Wnt5a loss-of-function alleles have been associated with
increased Wnt/b-catenin signaling (Gao et al., 2011; Mikels
et al., 2009; Topol et al., 2003). Taken together, these studies
suggest the existence of a Wnt5a/Ror2 pathway that inhibits Wnt/b-catenin signaling in vivo. However, it is unknown whether this
is the sole or dominant activity of Wnt5a. In particular, the
question of whether mammalian Wnt5a also has the capacity to
activate Wnt/b-catenin signaling in vivo remains unexplored.
The severe developmental phenotype observed in conventional
Wnt5a-knockout mice precludes a straightforward analysis of Wnt5a-
signaling. To uncover the potential signaling activities of Wnt5a
during mammalian development, we therefore generated a novel,
inducible transgenic mouse model that allows tight spatiotemporal
control over Wnt5a expression. Our experiments reveal multiple
phenotypes caused by ectopic Wnt5a expression, some of which
can be linked to the inhibition of Wnt/b-catenin signaling and others
to its activation. First, overexpression of Wnt5a in the developing skin
results in a loss of hair follicle formation, coinciding with a decrease in
b-catenin/TCF reporter activity in the dermis and revealing a pre-
viously unrecognized role for Wnt5a/Ror2 in patterning of the skin.
Second, Wnt5a overexpression causes delayed bone formation in the
developing skull. Unexpectedly, this is preceded by an increase in
b-catenin/TCF reporter activity in the calvarial mesenchyme, suggest-
ing that Wnt5a can induce Wnt/b-catenin signaling in vivo. Taken
together, our studies uncover novel roles for Wnt5a and its receptors
during development and reveal a dual signaling capacity for Wnt5a in
an intact, complex organism.Materials and methods
Animals
The tetO-Flag-Wnt5A transgenic construct was generated by clon-
ing a Flag-tagged version of mouseWnt5a downstream of an artiﬁcial
signal sequence into the pTRE-tight vector (Clontech). Fourteen
independent mouse lines (F5A-1 through F5A-14) were generated
initially by injecting the transgenic construct into FVB oocytes. Four
additional founder lines (F5A-15 through F5A-18) were generated in a
second round of injection. The vast majority of experiments in this
paper were performed with line F5A-5, which we have since replaced
with line F5A-17. TetO-Flag-Wnt5A mice were kept on an FVB back-
ground, although all complex crosses were performed on a mixed
background. Rosa26-rtTA-M2 mice (Hochedlinger et al., 2005) were
obtained from Jackson Laboratories (stock #006965). Axin2-lacZ
(Lustig et al., 2002) and TOPGAL (DasGupta and Fuchs, 1999) reporter
mice were obtained from Dr. W. Birchmeier (Max Delbruck Center,
Berlin-Buch, Germany) and Dr. E. Fuchs (Rockefeller University, New
York, USA), respectively. The tetO-Dkk mice (Chu et al., 2004) were
obtained from Dr. S. Millar (University of Pennsylvania, Philadelphia,
USA), Ror2-knockout mice (Takeuchi et al., 2000) from Dr. Y. Minami
(Kobe University, Kobe, Japan) andWnt5a-knockout mice (Yamaguchi
et al., 1999) were a gift from Dr. E. Vladar and Dr. J. Axelrod (Stanford
University, USA). Mice were housed at the Stanford University
Medical Center. All experiments were approved by the Stanford
University Animal Care and Use Committee and performed according
to NIH guidelines.Genotyping
Tail clippings were lysed overnight at 55 1C in Direct PCR lysis
reagent (Viagen Biotech, Inc., Los Angeles, CA, USA) supplemented
with proteinase K (100 ug/ml, Roche). Following heat inactivation
at 85 1C, the lysate was used for PCR with the following primers:
tetO-Wnt5A (transgene speciﬁc product, annealing at 55 1C):
Fwd: ACAAAGACGATGACGACAAGC Rev: CGCACCTTCTCCAAT-
GTACTG
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60 1C): Fwd: CTGGGAGTTGAGCAGCCTAC Rev: AGAGCAC-
AGCGGAATGACTT.
Axin2-lacZ and TOPGAL (transgene speciﬁc product, annealing
at 55 1C): Fwd: ATCCTCTGCATGGTCAGGTC Rev: CGTGGC-
CTGATTCATTCC.
Ror2-knockout (WT band 500 bp; KO band 200 bp, annealing
at 61 1C): WT Fwd: CTTAACTGTTCTAGGTCAAGTATG WT Rev:
CCTACTATAGACTCTGATCCTTCTGCC. Mutant Rev: ATCGCCTTC-
TATCGCCTTCTTGACGAG.
Wnt5a-knockout (WT band 484 bp; KO band 400 bp, annealing
at 55 1C): WT Fwd: GAGGAGAAGCGCAGTCAATC WT Rev:
CATCTCAACAAGGGCCTCAT Mutant Fwd: GCCAGAGGCCACTT-
GTGTAG.
Induction of tetO-Wnt5a transgene expression in vivo
Timed matings were set up and the morning on which a
vaginal plug was discovered was designated E0.5. Induction of
transgene expression during embryogenesis from the indicated
timepoints onwards was achieved by dissolving doxycycline
(Sigma) in the drinking water of pregnant dams. Unless otherwise
indicated, mice received a ﬁnal concentration of 1–2 mg/ml
doxycycline. The doxycycline containing drinking water was
refreshed three times per week.
Induction of tetO-Wnt5a transgene expression in vitro
Primary mouse embryo ﬁbroblasts (MEFs) were isolated and
cultured in a 3T3 protocol according to Jacobs et al. (1999). Early
passage MEFs from tetO-Wnt5A transgenic embryos or wildtype
littermates were infected with a mix of pBabe-TBX2 (blasticidin
resistance) and pBabe-rtTA3 (puromycin resistance) retroviruses to
allow for immortalization and inducible expression of the tetO-
Wnt5a transgene, respectively. Alternatively, transgene expression
was induced in double-heterozygous tetO-Wnt5a;R26-rtTA MEFs.
Cells were grown in Dulbecco’s modiﬁed Eagle’s medium supple-
mented with 10% fetal bovine serum, glutamine, penicillin/strepto-
mycin and 50 mM b-mercaptoethanol under 5% CO2 at 37 1C in
humidifying conditions. To induceWnt5a transgene expression, cells
were cultured in the presence of 1 ug/ml doxycycline overnight
(TBX2-infected MEFs), or in the presence of a concentration series of
doxycycline for 3–5 days (tetO-Wnt5a;R26-rtTA MEFs), after which
cells were lysed to extract RNA or protein.
Quantitative RT-PCR
RNA was isolated using an RNeasy Mini Kit (Qiagen) with on
column DNAse digestion. cDNA was synthesized using random
hexamer primers and the Thermoscript II RT-PCR system for First-
Strand Synthesis (Invitrogen). Quantitative PCRs were performed
on a Roche LightCycler (Roche) using the LightCycler Fast Start DNA
Master Plus SYBR green I mix (Roche) with the following primers:tetO-Wnt5a: Fwd: GCGTGGCTATGACCAGTTTA Rev:
CTACAAATGTGGTATGGCTGATTA
mGAPDH: Fwd: CTGGTGCTGCCAAGGCT Rev:
CTGCTTCACCACCTTCTTGATGTCATCATAProtein isolation and Western blotting
Cells were lysed in RIPA buffer supplemented with Complete
Protease Inhibitor Cocktail (Roche). Equal amounts of lysate
(or puriﬁed Wnt5a protein; see below) were run on a 10% SDS/PAGE gel. Following Western blot transfer, membranes were
blocked in TBST with 3% milk and 2% BSA. Wnt5a protein was
detected using a primary antibody directed against the Flag tag
(M1, Sigma) or Wnt5a (RnD), a secondary HRP-conjugated anti-
body (Santa Cruz Biotechnology) and ECL (Perkin Elmer). Ror2
protein expression was detected using hybridoma supernatant
(1:100) containing the anti-Ror2 mouse monoclonal previously
generated by our lab ((Mikels et al., 2009), available through the
Developmental Studies Hybridoma Bank). An antibody detecting
tubulin (Sigma) was used as a loading control.
Wnt5a protein puriﬁcation and luciferase assays
Flag-tagged Wnt5a protein was puriﬁed from stably transfected
S2 cells by consecutive afﬁnity chromatography and gel ﬁltration
steps as described previously (Mikels and Nusse, 2006; Willert
et al., 2003). Peak fractions were identiﬁed byWestern blot analysis
and used in luciferase assays. To test the efﬁcacy of Flag-Wnt5a in
inhibiting the activity of Wnt3a, 293T cells transfected with the
SuperTOPFLASH luciferase reporter and CMV-b-galactosidase for
normalization were treated with different combinations of puriﬁed
Wnt3a and Wnt5a. To test the ability of Flag-Wnt5a to induce b-
catenin/TCF signaling, 293T cells were transfected with Super-
TOPFLASH, CMV-b-galactosidase, Fzd4 and LRP5, and treated with
puriﬁed Wnt3a or Wnt5a. Following overnight stimulation with
puriﬁed Wnt proteins, cells were lysed and luciferase and b-
galactosidase activities were measured using the Tropix Dual Light
Reporter Gene Assay System (Applied Biosystems) on a Berthold
luminometer (Berthold Technologies).
Histology and immunohistochemistry
Tissue samples were ﬁxed in 4% paraformaldehyde, washed in
PBS, dehydrated through a graded ethanol series, cleared in
orange terpene and embedded in parafﬁn. For wholemount
analysis of dorsal skins, samples were ﬂat mounted and imaged
under a dissecting scope (Leica) when they were in 70% ethanol.
Contrast and color in these images were enhanced in Photoshop
in order to better visualize pigmentation. Tissue blocks were
sectioned on a microtome at 3–6 mm thickness, mounted on
Superfrost glass microscope slides (Fisher Scientiﬁc) and left to
dry at 37 1C overnight. For further processing, sections were
deparafﬁnized in orange terpene and rehydrated in a graded
ethanol series. For H&E staining, slides were stained in hematox-
ilin (Sigma) and eosin Y (Sigma). For immunohistochemistry,
antigen retrieval was performed in Tris/EDTA (pH 9.0). Endogen-
ous peroxidase activity was blocked by incubating the sections
with 0.3% H2O2. Slides were blocked using the Vector M.O.M. kit
(Vectorlabs). Primary antibody incubation was performed with
the anti-Ror2 mouse monoclonal (1:1000) described previously
(Mikels et al., 2009) or a rabbit polyclonal antibody raised against
Wnt5a (previously generated in our lab) at room temperature for
4 h or overnight. After this, tissue sections were further processed
using the Vectastain ABC system (Vectorlabs). Antibody binding
was detected with VIP or DAB substrate (Vectorlabs). Following
dehydration in a graded ethanol series and orange terpene,
coverslips were sealed with Cytoseal-60 (Thermo Scientiﬁc).
Images were acquired on a Zeiss upright microscope equipped
with an Axiocam CCD camera.
Detection of endogenous AP and lacZ reporter gene activity
To visualize endogenous alkaline phosphatase (AP) activity in
primary hair follicles, E14.5 embryos were processed according to
Nagy et al. with minor modiﬁcations (Nagy et al., 2007). Embryos
were ﬁxed in 4% PFA for 30 min, rinsed in PBS and AP buffer, after
Fig. 1. A novel transgenic mouse model allowing inducible Wnt5a overexpression.
(A) Schematic representation of the tetO-Wnt5A transgenic construct and the
experimental strategy. Mouse Wnt5a was cloned downstream of an artiﬁcial
signal sequence (SS) in frame with an N-terminal FLAG tag under the control of a
doxycycline inducible promoter. Transgene expression is only switched on in the
presence of both an rtTA driver and doxycycline (DOX). (B) Western blot analysis
illustrating that Wnt5a protein can be detected with an anti-Flag antibody in tetO-
Wnt5A transgenic mouse embryo ﬁbroblasts infected with pBabe-rtTA3 in the
presence (right) but not in the absence (left) of doxycycline. (C) External
appearance of a newborn tetO-Wnt5a;R26rtTA double-transgenic animal (right)
and a littermate control (left) following treatment with doxycycline from E11.5-
P0. Wnt5a overexpressing mice are smaller, have shortened limbs and an easily
identiﬁable craniofacial phenotype. Insert depicts treatment schedule.
R. van Amerongen et al. / Developmental Biology 369 (2012) 101–114104which AP activity was detected with BM Purple substrate (Roche)
in the dark at room temperature. Wholemount X-gal staining was
performed according to Hogan (1994) with minor modiﬁcations.
Organs from E14.5 or E16.5 embryos were microdissected follow-
ing ﬁxation (in PBS with 0.2% glutaraldehyde, 5 mM EGTA (pH
8.0) and 2 mM MgCl2). Tissues were washed in detergent rinse
(PBS with 2mMMgCl2, 0.01% sodium deoxycholate and 0.02% NP-40)
and stained in staining solution (PBS with 2mMMgCl2, 0.01% sodium
deoxycholate, 0.02% NP-40, 5 mM potassium ferricyanide, 5 mM
potassium ferrocyanide and 1mg/ml X-gal) in the dark at room
temperature overnight. Following staining, tissues were washed in
detergent rinse, post-ﬁxed in 4% paraformaldehyde and processed for
parafﬁn embedding. Wholemount tissues were photographed under
a dissecting scope (Leica) when samples were in 70% ethanol. Parafﬁn
sections of X-gal stained tissues were counterstained with nuclear
fast red. In all cases, tetO-Wnt5a;R26rtTA double-transgenics were
compared to control mice from the same litter, the samples of which
were processed at the same time and for the same duration and
analyzed simultaneously.
Skeletal stainings
Skulls and skeletons from newborn mice were processed for
Alizarin Red and Alcian Blue staining to detect bone and cartilage
(McLeod, 1980). In short, tissues were ﬁxed in 100% ethanol,
washed in 100% acetone, stained in Alizarin Red and Alcian Blue
for 3 days at 37 1C, cleared in 1% KOH and processed through a
graded glycerol series. Cleared specimens were stored in 100%
glycerol and imaged under a dissecting scope (Leica).
Quantiﬁcation of hair follicle number, animal size and bone length
To quantify the number of hair follicles in newborn skin,
images of H&E stained sections were imported in Image J.
A freehand line was drawn to trace and measure the length (in
pixels) of a continuous stretch of longitudinally oriented skin (as
determined by the orientation of the sub-dermal muscle ﬁbers).
The number of hair follicles in this stretch of skin was counted by
hand. Hair follicle number was divided by the length of the skin in
pixels. The resulting ratio, designated the ‘number of hair follicles
per unit length’ was plotted.
To determine the relative size of newborn mice, images of
double-heterozygotes photographed together with littermate
controls were imported in Image J. A freehand line was drawn
to trace and measure (in pixels) the distance from the nose, along
the back of the animal to the tip of the tail. For each control
littermate, this measurement was set at 100% and the size
reduction in double-heterozygotes was calculated accordingly.
To quantify the reduction in bone length, images of Alazarin
Red and Alcian Blue stained limbs were imported in Image
J. A straight line was drawn from the distal to the proximal end
of the bone. The measured distance (in pixels) was then used as a
relative measure for bone length.Results
Generation and characterization of tetO-Wnt5a transgenic mice
To uncover the potential signaling activities of Wnt5a in vivo,
we generated an inducible transgenic mouse model allowing tight
spatiotemporal control over Wnt5a expression. For this purpose,
we cloned a Flag-tagged version of the mouse Wnt5a gene
downstream of a tetracycline inducible promoter (Figs. 1A and
S1A in the supplementary data). Activity of Flag-tagged Wnt5a
was comparable to that of the untagged protein (Fig. S1B–D in thesupplementary data), allowing us to routinely purify large quan-
tities of bioactive Flag-Wnt5a according to previously published
protocols (Mikels and Nusse, 2006). Transgenic mice were gen-
erated by oocyte injection of the tetO-Flag-Wnt5a (hereafter tetO-
Wnt5a) construct. Mouse embryo ﬁbroblasts from individual
transgenic founder lines were tested in vitro for doxycycline-
inducible expression of the transgene by quantitative RT-PCR
(Fig. S2 in the supplementary data) and Western blot analysis
(Fig. 1B) to identify lines that showed robust induction of Flag-
Wnt5a expression. Furthermore, transgene induction was shown
to be dose-dependent by testing a concentration series of dox-
ycycline (Fig. S2 in the supplementary data). All phenotypes
discussed below were conﬁrmed to be present in at least two
independent tetO-Wnt5a lines.
Generalized overexpression of Wnt5A throughout embryonic
development is lethal
Transgene expression can be induced in vivo by crossing tetO-
Wnt5a mice to a strain expressing the appropriate rtTA driver, after
which the expression of Wnt5A can be switched on during embryo-
nic development by the administration of doxycycline in the
drinking water of pregnant dams (Fig. 1A). To determine the effect
of broad Wnt5a overexpression during embryonic development,
we set up timed matings between tetO-Wnt5a mice and mice
Table 1
Mendelian ratios of tetO-Wnt5a;R26rtTA mice. Offspring from a cross between
parents heterozygous for either tetO-Wnt5a or R26rtTA was born at the expected
Mendelian ratios when doxycycline treatment of pregnant mothers was started
from E13.5 onwards. In contrast, no double-transgenic offspring was recovered at
birth when Wnt5a overexpression was induced from, or prior to, E7.5.
tetO-Wnt5a;R26rtTA Wnt5a inducedrE7.5n Wnt5a inducedZE13.5nn
Expected Observed Expected Observed
wt;wt 8.5 8 9 10
wt;het 8.5 10 9 6
het;wt 8.5 16 9 7
het;het 8.5 0 9 13
n n¼34, P¼0.0015 (chi square test).
nn n¼36, P¼0.34 (chi square test).
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et al., 2005, hereafter R26rtTA). Expectant mothers were treated with
doxycycline for various amounts of time during pregnancy, after
which newborn mice were analyzed at birth. In the absence of
doxycycline, the different genotypes were observed at the expected
Mendelian ratios (data not shown). However, when doxycycline
treatment was started on or prior to E7.5, no tetO-Wnt5A;R26rtTA
double-heterozygotes were recovered among the offspring (Table 1,
P¼0.0015). In contrast, treatment from E13.5 onwards again yielded
the expected ratios of tetO-Wnt5A;R26rtTA double-heterozygotes at
birth (Table 1). Since we were able to recover tetO-Wnt5A;R26rtTA
double-transgenic mice at birth when doxycycline treatment was
started on or after E10.5 (see below), this suggests a critical time
window prior to E10.5 when generalized overexpression of Wnt5a is
lethal.
Wnt5a overexpression during the second half of pregnancy results in
a variety of defects
Double heterozygous tetO-Wnt5A;R26rtTAmice that were born
following transgene induction from E13.5 onwards were slightly
smaller than their control littermates, had trouble breathing and
did not survive (data not shown). We next determined that the
earliest timepoint at which doxycycline treatment could be
initiated while still allowing double-heterozygotes to be recov-
ered at birth, was E10.5. These mice were stillborn and were
easily identiﬁed by their external appearance. When doxycycline
treatment was started at E11.5 or E12.5, double heterozygous
animals showed a similar aberrant gross morphology and an
approximate 10% reduction in size compared to their control
littermates (Figs. 1C and S3 in the supplementary data). Closer
inspection of these newborn tetO-Wnt5A;R26rtTA mice revealed
phenotypes in multiple tissues. Most strikingly, virtually all
double-transgenic mice lacked most of their intestinal tract.
Whereas these mice had a stomach and hindgut, the small
intestine was largely absent (Fig. S4 in the supplementary data).
In addition, double heterozygotes had lung defects (RvA and RN,
unpublished data) as well as abnormalities in the skin and
multiple skeletal malformations (see below).
Global Wnt5a overexpression causes a Wnt/b-catenin loss-of-
function phenotype in the skin
Given the reported role for Wnt5a in repressing Wnt/b-catenin
signaling in vivo, both in normal development and disease
(Nemeth et al., 2007; Roarty et al., 2009; Topol et al., 2003), we
hypothesized that at least some of the phenotypes observed in
tetO-Wnt5a;R26rtTA mice would reﬂect this particular signaling
activity of Wnt5a. To distinguish between this and potential other
activities of Wnt5a, we decided to compare the phenotype of miceoverexpressing Wnt5a to that of mice overexpressing the known
secreted Wnt/b-catenin inhibitor Dickkopf1 (Dkk1) (Glinka et al.,
1998). Since the effects of global Dkk1 overexpression have not
been reported, we crossed both the tetO-Wnt5a mice and pre-
viously generated tetO-Dkk mice (Chu et al., 2004), to R26rtTA
driver mice and compared newborn tetO-Wnt5a;R26rtTA and tetO-
Dkk;R26rtTA pups following doxycycline treatment from E10.5
onwards. To our surprise, the gross phenotype of generalized
Dkk overexpression was much less severe than that of Wnt5a
overexpression. TetO-Dkk;R26rtTA mice were born alive at the
expected Mendelian ratios and could not be distinguished from
control littermates based on their overall appearance (data
not shown). Moreover, tetO-Dkk;R26rtTA double-transgenic mice
were readily recovered when doxycycline treatment was initiated
at E7.5, in contrast to what we observed for tetO-Wnt5a;R26rtTA
mice (data not shown).
Overexpression of Dkk1 in the basal layers of the developing
epidermis was previously reported to cause a complete loss of
hair follicles in the dorsal skin and to result in aberrant and
reduced vibrissiae formation (Andl et al., 2002). This phenotype
was recapitulated in tetO-Dkk;R26rtTA double-transgenic mice
that were treated with doxycycline from E10.5 onwards (Fig. 2A
and B and data not shown). Interestingly, we observed a similar
phenotype in the skin of double-transgenic tetO-Wnt5a;R26rtTA
mice (Figs. 2C–D and S5 in the supplementary data). Loss of hair
follicle formation is not only observed in mice overexpressing
Dkk1, but also in mice conditionally deﬁcient for b-catenin
(Huelsken et al., 2001) and in mice displaying the combined loss
of TCF3/TCF4 (Nguyen et al., 2009). Therefore, this phenotype
bears the hallmarks of a typical Wnt/b-catenin loss-of-function
phenotype.
Wnt5a overexpression inhibits the second wave of hair follicle
formation
Whereas Dkk overexpression resulted in the complete loss of
hair follicles in the dorsal skin (Fig. 2B), some hair follicles were
found to be remaining in the skin of Wnt5a-overexpressing
mice (Fig. 2D). In most cases however, these follicles failed
to progress beyond the embryonic hair germ or hair peg stage
(white arrowheads in Fig. 2D). Quantiﬁcation of the number of
remaining follicles in the dorsal skin of tetO-Wnt5A;R26rtTA
mice showed a clear decrease at the time of birth (Fig. 2I). Of
note, the absolute reduction in hair follicle number did not
change with earlier onset of doxycyline treatment. Regardless of
when Wnt5a overexpression was initiated between E10.5 and
E13.5, there was a 58% (7 8%) decrease in the number of hair
follicles that could be counted at birth. In addition, the extent to
which remaining hair follicles developed was also comparable
(Fig. 2 E–H). While some hairs appeared to mature normally
(arrowhead in Fig. 2F), on average the growth of remaining hair
follicles was delayed compared to control skin (compare for
instance Fig. 2H–G).
Hair follicle formation in the mouse skin occurs in three waves
(reviewed in Duverger and Morasso, 2009), the ﬁrst of which
takes place around E14.5. When we compared sections from the
developing skin of E14.5 embryos treated with doxycycline from
E10.5 onwards, hair placodes were readily detectable in both
control and Wnt5a-overexpressing skin (Fig. 3A–B), suggesting
that this primary wave of hair follicle formation was initiated
normally. This was conﬁrmed by wholemount analysis of E14.5
embryos, in which primary hair follicle formation can be visua-
lized by alkaline phosphatase staining (Fig. 3C). At E16.5 however,
when the second wave of hair follicle formation commences, the
total number of hair follicles in the skin from Wnt5a overexpres-
sing mice appeared to be reduced (Fig. 3D–E). Taken together
Fig. 2. Global overexpression of Wnt5a or Dkk1 results in loss of hair follicle formation in the dorsal skin. (A–D) H&E stained histological tissue sections from the dorsal
skin of tetO-Dkk;R26rtTA (B) and tetO-Wnt5a;R26rtTA (D) double-transgenic mice and their respective littermate controls (A and C), showing that both Wnt5a and Dkk1
overexpression results in loss of hair follicle formation. Transgene induction was achieved by administering doxycycline from E10.5 to P0. (E–H) H&E stained histological
tissue sections showing representative images of the dorsal skin from newborn tetO-Wnt5a;R26rtTA mice, illustrating that a reduction in hair follicle numbers occurs
regardless of whether doxycycline treatment was initiated at E10.5 (E), E11.5 (F) or E13.5 (G–H). In addition to their overall number being lower, remaining hair follicles
were less mature, although some did show signs of keratinization (white arrowhead in F). (I) Graph depicting the quantiﬁcation of hair follicle numbers in the skin of
newborn mice overexpressing Wnt5a from E10.5-P0, E11.5-P0, E12.5-P0 or E13.5-P0 relative to littermate controls. Sagittal sections from a total of 38 skins were counted.
Control samples (n¼16) derived from the different doxycycline treated litters were pooled to calculate the average number of hair follicles per unit length in control skin.
A comparable and statistically signiﬁcant reduction in hair follicle numbers was observed in all Wnt5a overexpressing newborn skins (npo1104 for onset at E10.5,
nnpo5104 for onset at E11.5 and nnnpo1105 for onset at E12.5 and E13.5, T-test). Error bars indicate standard deviation. Scale bar is 100 mm in A–H.
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affect the initial formation of hair placodes at E14.5, but results in
a reduction in the number of hair follicles at birth. Thus, we
conclude that Wnt5a overexpression affects the second and third,
but not the ﬁrst, wave of hair follicle formation in the skin.
Wnt5a overexpression affects hair follicle spacing through inhibition
of Wnt/b-catenin signaling in the dermis
To test if Wnt5a overexpression indeed resulted in inhibition
of Wnt/b-catenin signaling in the skin, we crossed a known Wnt/
b-catenin reporter strain, Axin2-lacZ (Lustig et al., 2002), into our
Wnt5a-transgenic mouse model and analyzed double-heterozy-
gous tetO-Wnt5a;R26rtTA embryos carrying an Axin2-lacZ allele
for changes in reporter gene expression. At E14.5, when hair
follicle formation has been initiated, Axin2-lacZ is broadly
expressed in wildtype skin (Fig. 4A), with the strongest expres-
sion seen in dermal condensates adjacent to hair placodes and in
the outer layers of the epidermis. In addition, prominent Axin2-
lacZ expression can be observed in a thin layer of dermal cells
immediately underlying the basal epidermis. The overall expression
of Axin2-lacZ is markedly reduced in the skin of tetO-Wnt5a;R26rtTA
double-transgenic littermates (Fig. 4B). In particular, most of the
expression observed in the dermis of control embryos is absent inWnt5a-transgenic mice. At E16.5, Axin2-lacZ expression in control
mice is widespread and observed in all layers of the epidermis, as
well as in the dermal papilla of growing hair follicles and in the
ﬁrst ﬁve cell layers of the dermis (Fig. 4C,E). In mice overexpres-
sing Wnt5a, growing hair follicles showed strong, and apparently
unchanged, Axin2-lacZ staining in the dermal papilla (Fig. 4D,
white arrowheads). Similarly, expression in most of the epidermis
appears to be unaffected. In contrast, Axin2-lacZ expression is
speciﬁcally reduced in the upper dermis of tetO-Wnt5a;R26rtTA
double-transgenic (Fig. 4D,F).
The tyrosine kinase receptor Ror2 can transduce a Wnt5a
signal resulting in inhibition of Wnt/b-catenin signaling in vitro.
We therefore hypothesized that Ror2 might play a similar role in
the developing skin. Ror2 has been reported to be expressed in
the skin, but the pattern has not been studied in detail (Al-Shawi
et al., 2001; DeChiara et al., 2000; Hu et al., 2010). Using an
antibody directed against mouse Ror2, we were able to detect
endogenous Ror2 protein expression in the developing skin at
both E14.5 (data not shown) and E16.5 (Fig. 4G–H) in control, but
not Ror2-deﬁcient animals. The highest levels of Ror2 were
expressed in the upper dermis, precisely where Wnt5a-over-
expression results in inhibition of the Wnt/b-catenin dependent
luciferase reporter Axin2-lacZ. Of note, we found that Axin2-lacZ
reporter gene expression in this stripe of cells was unchanged in
Fig. 3. Wnt5a overexpression inhibits the second, but not the ﬁrst wave of hair follicle formation. (A–B) H&E stained histological tissue sections of E14.5 dorsal skin,
showing that hair placodes (white arrowheads) are formed in both tetO-Wnt5a;R26rtTA double-heterozygous embryos and littermate controls when doxycycline is
administered from E10.5-E14.5. (C) Wholemount alkaline phosphatase staining of E14.5 embryos, revealing a normal pattern of primary hair follicle induction in Wnt5a-
transgenic mice (right) following doxycycline administration from E10.5-E14.5. (D–E) H&E stained histological tissue sections of E16.5 dorsal skin, showing a reduction in
the number of hair follicles (white arrowheads) in Wnt5a-transgenic mice following doxycycline administration from E10.5-E16.5. Scale bars are 100 mm in A–B and D–E.
Fig. 4. Loss of Wnt/b-catenin signaling at sites of Ror2 expression in the dermis of Wnt5a-overexpressing mice. (A–F) Histological tissue sections of wholemount X-gal
stained dorsal skin, demonstrating that expression of the Wnt/b-catenin reporter Axin2-lacZ is markedly reduced in Wnt5a-transgenic embryos at both E14.5 (A–B) and
E16.5 (C–F). Mice depicted in A and B are littermates, as are the mice depicted in C and D. The activity of an independent Wnt/b-catenin reporter strain, TOPGAL, was also
reduced at these timepoints (data not shown). (A–B) At E14.5 the overall activity of Axin2-lacZ is lower throughout the epidermis and dermis of Wnt5a overexpressing
mice, but expression of the reporter is particularly reduced in the dermal condensates. (C–D) At E16.5 the Axin2-lacZ signal in the dermal papilla of existing hair follicles
remains largely unaffected (white arrowheads in D). (E–F) Close-ups of the control and Wnt5a overexpressing skins shown in C and D, showing that the most dramatic
reduction in Wnt/b-catenin reporter gene expression is seen in a thin layer of cells just underlying the basal layer of the epidermis in tetO-Wnt5a;R26rtTA double-
heterozygous mice (F) but not in littermate controls (E). (G–H) Immunohistochemical detection of endogenous Ror2 protein expression in the dermis of control (G) but not
Ror2-knockout (H) skin at E16.5. Dashed lines indicate the boundary between epidermis and dermis. Dotted lines in G and H indicate the outermost cell layer of the
epidermis. Scale bars are 100 mm in A–B, 20 mm in C and D, and 50 mm in E–H.
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Dkk inhibits b-catenin/TCF signaling in a Ror2-independent fash-
ion (Fig. S6 in the supplementary data). Taken together, our datasupport a model in Wnt5a/Ror2 inhibits dermal Wnt/b-catenin
signaling to control the progression of hair follicle formation
during embryonic development.
Fig. 5. Global overexpression of Wnt5a causes multiple skeletal defects. (A–L) Wholemount preparations of newborn Wnt5a-overexpressing and control skeletons, stained
with Alizarin Red and Alcian Blue to visualize bone (red) and cartilage (blue) following transgene expression from E10.5-P0 (B,F,J), E11.5-P0 (C,G,K) or E12.5-P0 (D,H,L).
TetO-Wnt5a;R26rtTA double-heterozygotes develop a split sternum (A–D) and have shortened bones in the fore (E–H) and hindlimbs (I–L) at the time of birth. (M) Graph
depicting the relative length of ﬂat (scapula) and long bones (humerus, ulna and tibia) in control (n¼3) and Wnt5a-overexpressing mice (n¼4), revealing that limb
outgrowth is more severely impaired than overall body size (Fig. S3C in the supplementary data). Data were pooled for animals treated with doxycycline from E10.5-P0,
E11.5-P0 and E12.5-P0. Error bars indicate standard deviation. (N–Q) Close-up images, demonstrating that bone formation in the extremities is delayed in Wnt5a-
overexpressing mice compared to littermate controls. This effect is more pronounced for tarsal (compare Q to P) than for carpal bones (compare O to N). Scale bar is 2 mm
in (A–L) and 1 mm in (N–Q).
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hair follicle formation, we sought to rescue the effects of Wnt5a
overexpression in the skin by introducing a Ror2 loss-of-function
allele (Takeuchi et al., 2000). Unfortunately, the interpretation of
these rescue experiments was not straightforward. In agreement with
published data (Hu et al., 2010), we initially did not detect any
obvious defects in the initiation or progression of hair follicle
formation in sections from the dorsal skin of Ror2-deﬁcient mice at
either E16.5 or P0 (Fig. S7A–D in the supplementary data). However,
upon wholemount analyses of the dorsal skin from newborn animals,
we noticed a large variation in hair follicle density in Ror2-null mice
(Fig. S7E–G in the supplementary data). Since hair follicles in (early)
anagen are easily identiﬁable as dark spots in wholemount prepara-
tions of the skin from newborn, pigmented animals, it thus appears
that Ror2-deﬁcient mice show aberrant hair patterning or pigmenta-
tion, albeit with incomplete penetrance. Consequently, we did not
observe restoration to wildtype numbers of hair follicles in Ror2-
deﬁcient tetO-Wnt5a;R26rtTA animals compared to tetO-Wnt5a;
R26rtTA littermates that were wildtype or heterozygous for Ror2
at either high (1 mg/ml doxycycline), intermediate (0.4 mg/mldoxycycline) or low (0.2 mg/ml doxycycline) levels of Wnt5a-trans-
gene expression (Fig. S8 in the supplementary data). In contrast, some
of these animals showed quite aberrant patterning, in which areas
with hair follicles at low density were bordered by regions in which
hair follicles appeared to be totally absent (Fig. S8O in the supple-
mentary data). This observation suggests a precarious balance in
Wnt5a/Ror2 signaling in the developing skin, the disruption of which
affects hair follicle patterning and spacing.
Wnt5a overexpression inhibits bone formation
The external appearance of tetO-Wnt5A;R26rtTA transgenic
mice also suggested prominent skeletal defects. Compared to
control littermates, mice overexpressing Wnt5a had shortened
limbs and prominent craniofacial abnormalities (Figs. 1C and S5
in the supplementary data), reminiscent of the phenotype pre-
viously reported for Col2a1-Wnt5a transgenic mice (Yang et al.,
2003). Closer inspection of skeletons from newborn mice revealed
that Wnt5a overexpression in the embryo (from either E10.5,
E11.5 or E12.5 until birth) caused a split sternum (Fig. 5A–D) and
Fig. 6. Delayed calvarial ossiﬁcation in Wnt5a-transgenic mice. Wholemount preparations of newborn Wnt5a-overexpressing and control skulls, stained with Alizarin Red
and Alcian Blue to visualize bone (red) and cartilage (blue) following transgene expression from E10.5-P0 (B,G,L) to E11.5 (C,H,M) or E12.5 (D,I,N) or E13.5 (E,J,O),
demonstrating that calvarial bone formation is reduced in the skull of Wnt5a-overexpressing mice compared to control littermates (A,F,K). (F–J) are top views of the skulls
depicted in (A–E) and (K–O) are close-ups of the same samples. Scale bar is 2 mm.
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hindlimbs (Fig. 5E–M). Although shortened, long bones were fully
ossiﬁed at the time of birth. In contrast, ossiﬁcation in the digits was
visibly delayed in Wnt5a-transgenic neonates, with reduced bone
formation in the metacarpal and phalangeal bones. This delay was
more prominent in the hindlimb than in the forelimb: When mice
were treated with doxycycline from E12.5 onwards, bone formation
was detectable in carpal (Fig. 5N–O), but absent in tarsal bones
(Fig. 5P–Q). We observed the most prominent reduction in bone
formation in the calvaria. Here, both the neural crest-derived frontal
bones and the mesoderm-derived parietal and interparietal bones
were affected (Fig. 6A–J). Compared to control littermates, the
meshwork of bone in the calvaria of newborn tetO-Wnt5a;R26rtTA
mice was less condensed (Fig. 6K–O), suggesting either a delay or a
block in ossiﬁcation. This phenotype was most apparent when
doxycline treatment was commenced between E10.5 and E12.5,
but even Wnt5a transgene expression from E13.5 onwards resulted
in reduced density of the calvarial bones (Fig. 6O). Since bone
formation in the limbs occurs through endochondral ossiﬁcation of
cartilage intermediates, whereas bone formation in the skull occurs
directly through intramembranous ossiﬁcation of a mesenchymal
progenitor, these results suggest that Wnt5a overexpression affects
both processes.
Reduced calvarial ossiﬁcation is preceded by gain of Wnt/b-catenin
signaling in the meninges
Wnt/b-catenin signaling is known to control multiple steps of
bone development (for reviews see Leucht et al., 2008; Williams
and Insogna, 2009). It is generally considered to promote bone
formation, as illustrated by the association of LRP5 gain and loss
of function mutations with familial high and low bone mass
phenotypes, respectively (Cui et al., 2011; Gong et al., 2001; Kwee
et al., 2005; Little et al., 2002). In fact, administration of Wnt
ligands is seen as a powerful tool to potentially increase bone
mass upon tissue damage or aging (Minear et al., 2010). Although
Dkk1 has previously been shown to negatively affect bone
formation (Morvan et al., 2006), we did not observe any defects
in calvarial ossiﬁcation in tetO-Dkk;R26rtTA-transgenic mice fol-
lowing doxycycline administration from E10.5-P0 (Fig. 7A–D).
We therefore hypothesized that the reduced bone formation inthe skull of newborn tetO-Wnt5a;R26rtTA double-heterozygous
mice might be due to a separate signaling activity of Wnt5a,
distinct from its ability to inhibit b-catenin/TCF signaling.
To test this, we again crossed the Axin2-lacZ reporter mice into
the tetO-Wnt5a;R26rtTA background to score changes in Wnt/b-
catenin activity. Independently, we also crossed in TOPGAL, a second
Wnt/b-catenin reporter strain (DasGupta and Fuchs, 1999). To our
surprise, we observed a consistent increase in b-catenin/TCF signal-
ing in the heads of mice overexpressing Wnt5a at E14.5 and E16.5
(Figs. 7E–P and S9 in the supplementary data). Both Axin2-lacZ
(Fig. 7E–F and M–N) and TOPGAL (Fig. 7G–H) reporter activity
showed an increase in tetO-Wnt5a;R26rtTA double-transgenics com-
pared to littermate controls. Thus, in contrast to the skin, where we
found Wnt5a overexpression to inhibit b-catenin/TCF signaling,
Wnt5a causes activation of Wnt/b-catenin signaling in the develop-
ing skull (see also Fig. S10 in the supplementary data).
Upon isolating the tissue with increased b-catenin/TCF signal-
ing by microdissection, we found it to be located between the
surface ectoderm and the brain, consistent with the location of
the developing calvarial mesenchyme. However, when we ana-
lyzed Axin2-lacZ reporter gene expression in parafﬁn embedded
tissue sections of E14.5 and E16.5 heads, we found that the
increase in Wnt/b-catenin signaling was restricted to the dura
mater, which is the outermost layer of the developing meninges
(Fig. 7I–L and O–P). The meninges is a neural crest derived tissue
that develops in close association with the underlying brain and
the overlying frontal and parietal bones (Jiang et al., 2002).
Of note, meningeal defects have previously been shown to
adversely affect bone formation during embryonic development
(Ito et al., 2003; Vivatbutsiri et al., 2008). Conversely, an intact
dura mater has been shown to aid in osteogenic repair following
calvarial defects (Levi et al., 2011). These studies, as well as our
own, suggest important crosstalk between the meninges and the
developing or healing calvaria. Our data suggest a previously
unrecognized role for Wnt/b-catenin signaling in this process.Discussion
It has long been debated whether individual Wnt ligands have
multiple signaling activities in vivo and, if so, how signaling
Fig. 7. Global Wnt5a overexpression causes an increase in Wnt/b-catenin signaling in the developing meninges. (A–D) Wholemount preparations of the skulls from
newborn mice, stained with Alizarin Red and Alcian Blue to visualize bone (red) and cartilage (blue), showing that overexpression of Wnt5a (compare B to A), but not Dkk1
(compare D to C) from E10.5-P0 results in reduced calvarial ossiﬁcation at birth. (E–H) Wholemount preparations of X-gal stained E14.5 embryos, demonstrating that
expression of the Wnt/b-catenin reporters Axin2-lacZ (compare F to E) and TOPGAL (compare H to G) is increased in the developing skull of Wnt5a-overexpressing mice
compared to control littermates. The skin was removed to better visualize the calvarial mesenchyme. (I–L) Histological tissue sections of the samples depicted in (E–F)
following parafﬁn embedding, showing that the increase in Axin2-lacZ activity is restricted to a thin layer of cells immediately underlying the calvarial mesenchyme and
overlying the brain, consistent with the location of the developing meninges. The sagittal (I–J) and coronal (K–L) planes of sectioning are indicated with the black lines in
panel (E). (M–N) Wholemount preparations of X-gal stained E16.5 embryos, demonstrating that expression of the Wnt/b-catenin reporter Axin2-lacZ (compare N to M) is
increased in the developing skull of Wnt5a-overexpressing mice compared to control littermates. The skin was removed to better visualize the developing skull. (O–P)
Independent coronal tissue sections of wholemount X-gal stained E16.5 embryos, showing an increase in Axin2-lacZ activity in the meninges. Scale bars are 2 mm in A–D,
1 mm in E–H and M–N, 100 mm in I–J and 50 mm in K–L and O–P. (br) brain, (cm) calvarial mesenchyme, (dm) dura mater, (sk) skin.
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organism. In recent years it has become evident that a single
Wnt protein can indeed initiate multiple downstream signaling
events. For instance, both Wnt5a and Wnt11 are required for axis
speciﬁcation in the early Xenopus embryo (Cha et al., 2008;
Tao et al., 2005), a process that is driven by Wnt/b-catenin
signaling. Yet each protein is also well known to have a
b-catenin-independent role in controlling convergent extension
movements at later developmental stages (Kim et al., 2008;
Wallingford et al., 2001). The ﬁnding that puriﬁed mouse Wnt5a
was able to both activate and inhibit Wnt/b-catenin signaling
in vitro (Mikels and Nusse, 2006), suggested that a similar paradigm
might apply to mammalian Wnt proteins. Existing mouse models
however, did not allow perturbation of Wnt5a expression in a
controlled manner, precluding the testing of this hypothesis in vivo.
Here we describe the generation of a novel, inducible trans-
genic mouse model, which offers many advantages over existingWnt5a-knockout and -transgenic mouse lines (Adamska et al.,
2005; Baxley et al., 2011; Yamaguchi et al., 1999; Yang et al.,
2003), including tight spatial and temporal control over the onset
and duration of Wnt5a overexpression. For our ﬁrst analysis,
we chose to study the effects of broad Wnt5a overexpression
during embryonic development, using a Rosa26-rtTA-M2 driver
(Hochedlinger et al., 2005). We found that elevated levels of
Wnt5a expression caused a variety of developmental defects that
diminished in severity with lower levels (achieved by lowering
the concentration of doxycycline) as well as later onset of
transgene induction. By focusing on two of these phenotypes in
more detail, we were able to uncover previously unrecognized
roles for the dermis in determining hair follicle formation and
patterning of the skin, as well as for Wnt/b-catenin signaling in
the meninges in controlling calvarial bone formation. Interest-
ingly, we were able to link these phenotypes to different signaling
activities of Wnt5a: On the one hand, we found that Wnt5a/Ror2
R. van Amerongen et al. / Developmental Biology 369 (2012) 101–114 111signaling inhibits Wnt/b-catenin signaling in the dermis (Fig. 4),
thereby affecting the second and third wave of hair follicle
formation. On the other hand, Wnt5a caused an increase in
Wnt/b-catenin signaling in the meninges (Fig. 7), preceding
diminished ossiﬁcation of the calvarial mesenchyme. To our
knowledge, this is the ﬁrst report of potential dual signaling
activities for a mammalian Wnt ligand during embryonic
development.
Wnt-signaling controls multiple aspects of hair follicle mor-
phogenesis, both during embryonic development and in postnatal
hair turnover. In addition to directing hair follicle formation, Wnt/
b-catenin signaling has also been shown to control hair follicle
spacing. Establishment of the hair follicle pattern in the skin
occurs according to a reaction-diffusion model, with Wnt proteins
serving as activators and Dkk proteins as diffusible inhibitors
(Plikus et al., 2011; Schlake and Sick, 2007; Sick et al., 2006). We
ﬁnd that the Wnt5a-mediated inhibition of hair follicle formation
(Figs. 2 and 3) coincides with a reduction in dermal Wnt/b-
catenin signaling (Fig. 4). Ror2 is normally expressed throughout
the dermis during this time (Fig. 4) and endogenous Wnt5a
is similarly expressed from E14.5 onwards, although its expres-
sion later becomes concentrated in dermal condensates (Reddy
et al., 2001). We therefore propose that endogenous Wnt5a/Ror2
signaling might help control hair follicle spacing by globally
dampening Wnt/b-catenin signaling, thereby preventing the pre-
cocious or extraneous hair follicle formation that can result from
ectopic b-catenin/TCF signaling (Narhi et al., 2008).
The fact that we were unable to rescue the loss of hair follicle
formation in tetO-Wnt5a;R26rtTA animals by introducing a Ror2-
null allele is puzzling in light of our earlier ﬁndings: Ror2 directly
binds Wnt5a through its CRD domain and expression of Ror2 is
sufﬁcient to confer Wnt5a-mediated inhibition of b-catenin/TCF
signaling, suggesting that it can act as a genuine Wnt receptor
(Mikels and Nusse, 2006). However, other studies have proposed
that Ror2 functions as a co-receptor for Fzd (Grumolato et al.,
2010; Ho et al., 2012; Nishita et al., 2010; Yamamoto et al., 2008).
As such, Ror2 might be involved in, but not be critically required
for, the Wnt5a-mediated inhibition of b-catenin/TCF signaling,
especially when the levels of Wnt5a are not limiting. One
complicating factor in interpreting these experiments is our
ﬁnding that loss of Ror2 alone causes a reduction in the number
of hair follicles in the skin of some, but not all, animals (Fig. S7 in
the supplementary data). Incomplete penetrance is something we
have also observed for other phenotypes in the Ror2-knockout
mice (RvA and RN, unpublished data) and might reﬂect functional
redundancy with Ror1, which shows overlapping expression with
Ror2 in some tissues during embryonic development (Al-Shawi
et al., 2001; Matsuda et al., 2001). At present, we have no
explanation for the defects in hair follicle spacing in Ror2-
deﬁcient mice, although it leaves open the possibility of a non-
cell autonomous role for Ror2, in which it could function to
sequester multiple Wnt ligands (both activators and inhibitors of
Wnt/b-catenin signaling) similar to its Caenorhabditis elegans
homologue cam1 (Green et al., 2007).
We uncovered a second signaling activity for Wnt5a in the
developing skull. Here, Wnt5a overexpression caused the induction
of Wnt/b-catenin signaling in the meninges (Fig. 7). This was
associated with reduced calvarial ossiﬁcation at birth (Figs. 6 and
7). Compared to endochondral bone formation, which occurs
through a cartilage intermediate, the process of intramembranous
ossiﬁcation remains relatively poorly understood. As ﬁrst glance our
ﬁndings appear counterintuitive to a paradigm in which Wnt/b-
catenin signaling is generally considered to promote bone forma-
tion. However, it was recently shown that high levels of Wnt/b-
catenin signaling inhibit the osteogenic differentiation of embryonic
calvarial mesenchymal cells, while inducing osteogenesis in maturecalvarial osteoblasts (Quarto et al., 2010). Whereas Wnt/b-catenin
signaling therefore appears to be required for bone formation, earlier
activation of the pathway might result in the prolonged mainte-
nance of a mesenchymal progenitor state. Although at present we
have no proof that in tetO-Wnt5a;R26rtTA double-transgenic animals
the increase in b-catenin/TCF signaling in the dura mater at E14.5
and E16.5 is directly responsible for the reduced bone formation
observed at birth, it is generally well accepted that the dura mater
affects osteogenesis in the overlying calvarial mesenchyme through
the secretion of paracrine growth factors (Li et al., 2007; Spector
et al., 2002; Vivatbutsiri et al., 2008). We therefore hypothesize that
the enhanced Wnt/b-catenin signaling in the dura mater alters the
production of one or more of these factors. Although the endogen-
ous role of Wnt-signaling in dura mater biology has not been
studied, both ligands and receptors are expressed in the developing
meninges as suggested by publicly available expression databases
(e.g. Gene Expression Database at http://www.informatics.jax.org).
These include Fzd4, which can induce Wnt/b-catenin signaling in
response to Wnt5a (Mikels and Nusse, 2006) and which might
therefore be responsible for the observed increase in Axin2-lacZ and
TOPGAL reporter activity in our Wnt5a overexpressing mice. At
present however, we cannot exclude that other signaling activities
of Wnt5a (such as a Ror2-mediated induction of osteoclastogenesis)
underlie the bone loss observed in the skull and limbs of tetO-
Wnt5a;R26rtTA double-transgenic mice (Maeda et al., 2012).
Of note, the block in calvarial ossiﬁcation was more sensitive
to dose than the loss of hair follicles in the skin or the loss of
intestinal tissue. The latter two were still observed when mice
were treated with lower levels of doxycycline (Figs. S4 and S8 in
the supplementary data). In contrast, loss of bone formation in
the skull was only detected when mice received 1–2 mg/ml
doxycycline. This suggests that the Wnt/b-catenin loss of function
phenotype is preserved at lower levels, whereas the induction of
Wnt/b-catenin signaling requires higher levels of Wnt5a trans-
gene expression. It is tempting to speculate that this might reveal
something about the afﬁnity of Wnt5a for its receptors: Much
higher levels of Wnt5a might be required to induce activation of
Wnt/b-catenin signaling through a particular Fzd receptor than to
inhibit it via Ror2. By incorporating loss-of-function alleles for
different receptors, as we have done here for Ror2, the tetO-Wnt5a
mouse model might help elucidate the factors that control the
speciﬁcity of ligand-receptor interactions. Furthermore, as the
arsenal of rtTA drivers expands, it will be possible to induce
tissue-speciﬁc overexpression at multiple sites, both in the
embryo and in the adult. We have already observed vast differ-
ences in phenotypic outcome depending on the promoter used to
drive Wnt5a overexpression in the developing lung (RvA and RN,
unpublished data).
Although our system relies on the ectopic expression of
Wnt5a, which may exert its activities at different sites than the
endogenous protein, tight control over the onset and levels of
ligand expression offers an important advantage in dissecting the
signaling responses in a complex, developing organism. Follow-up
studies using conditional knockout mice will be required to test
the requirement for endogenous Wnt5a, or another Wnt protein,
in the biological processes discussed here. In conclusion, although
Wnt5a is generally not associated with signaling through
b-catenin/TCF, our current study suggests that it is able to do so
in vivo. While it remains to be determined whether Wnt5a indeed
activates Wnt/b-catenin signaling under physiological conditions
in mammals, this ﬁnding is of special interest given the dual, and
confusing, roles reported for Wnt5a in oncogenesis. Wnt5a has
been ascribed both oncogenic and tumor suppressor properties in
human malignancies (Kurayoshi et al., 2006; McDonald and
Silver, 2009; O’Connell et al., 2010; Peng et al., 2011; Roman-
Gomez et al., 2007; Yamamoto et al., 2010; Ying et al., 2007).
R. van Amerongen et al. / Developmental Biology 369 (2012) 101–114112The current data suggest that especially when overexpressed at
ectopic sites, its signaling activities should be carefully analyzed
and the possibility of Wnt5a driving b-catenin/TCF signaling
should be considered.Acknowledgments
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